Geode Capital Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.1M Sell
1,074,049
-2,497
-0.2% -$30.6K ﹤0.01% 2175
2025
Q1
$15.4M Buy
1,076,546
+35,436
+3% +$508K ﹤0.01% 2035
2024
Q4
$16.6M Sell
1,041,110
-13,052
-1% -$208K ﹤0.01% 2066
2024
Q3
$25.3M Buy
1,054,162
+16,065
+2% +$386K ﹤0.01% 1852
2024
Q2
$20.7M Buy
1,038,097
+25,899
+3% +$516K ﹤0.01% 1918
2024
Q1
$20.2M Buy
1,012,198
+21,413
+2% +$426K ﹤0.01% 1926
2023
Q4
$22.2M Buy
990,785
+43,039
+5% +$965K ﹤0.01% 1846
2023
Q3
$19.2M Buy
947,746
+37,180
+4% +$752K ﹤0.01% 1851
2023
Q2
$23.3M Buy
910,566
+32,826
+4% +$839K ﹤0.01% 1752
2023
Q1
$26.1M Buy
877,740
+31,152
+4% +$926K ﹤0.01% 1628
2022
Q4
$22.9M Buy
846,588
+19,331
+2% +$523K ﹤0.01% 1677
2022
Q3
$18M Buy
827,257
+5,788
+0.7% +$126K ﹤0.01% 1812
2022
Q2
$22.5M Sell
821,469
-16,196
-2% -$443K ﹤0.01% 1686
2022
Q1
$28.1M Buy
837,665
+22,417
+3% +$751K ﹤0.01% 1663
2021
Q4
$28.3M Buy
815,248
+7,557
+0.9% +$262K ﹤0.01% 1726
2021
Q3
$25.2M Buy
807,691
+15,517
+2% +$484K ﹤0.01% 1788
2021
Q2
$28.8M Buy
792,174
+28,746
+4% +$1.05M ﹤0.01% 1718
2021
Q1
$33.4M Buy
763,428
+45,830
+6% +$2M 0.01% 1525
2020
Q4
$32.9M Buy
717,598
+47,507
+7% +$2.18M 0.01% 1395
2020
Q3
$22.3M Sell
670,091
-20,058
-3% -$666K ﹤0.01% 1465
2020
Q2
$20.3M Buy
690,149
+11,861
+2% +$349K ﹤0.01% 1502
2020
Q1
$18.3M Buy
678,288
+51,209
+8% +$1.38M ﹤0.01% 1359
2019
Q4
$21.1M Buy
627,079
+23,532
+4% +$793K ﹤0.01% 1534
2019
Q3
$22.6M Buy
603,547
+13,276
+2% +$497K 0.01% 1400
2019
Q2
$25.7M Buy
590,271
+39,678
+7% +$1.73M 0.01% 1315
2019
Q1
$23.5M Buy
550,593
+40,841
+8% +$1.74M 0.01% 1304
2018
Q4
$22.8M Buy
509,752
+48,245
+10% +$2.16M 0.01% 1196
2018
Q3
$31.6M Buy
+461,507
New +$31.6M 0.01% 1087
2018
Q2
Sell
-403,936
Closed -$18.6M 4070
2018
Q1
$18.6M Sell
403,936
-99,638
-20% -$4.59M 0.01% 1313
2017
Q4
$23.3M Buy
503,574
+30,174
+6% +$1.39M 0.01% 1160
2017
Q3
$21.3M Buy
473,400
+58,401
+14% +$2.63M 0.01% 1187
2017
Q2
$16.3M Buy
414,999
+13,623
+3% +$535K 0.01% 1349
2017
Q1
$15.3M Buy
401,376
+49,142
+14% +$1.87M 0.01% 1350
2016
Q4
$13M Buy
352,234
+19,705
+6% +$729K 0.01% 1414
2016
Q3
$11.5M Buy
332,529
+9,544
+3% +$331K 0.01% 1401
2016
Q2
$10.5M Buy
322,985
+27,282
+9% +$887K 0.01% 1397
2016
Q1
$8.5K Buy
295,703
+5,294
+2% +$152 ﹤0.01% 1506
2015
Q4
$9.7M Buy
290,409
+12,666
+5% +$423K 0.01% 1407
2015
Q3
$7.9M Buy
277,743
+2,701
+1% +$76.8K ﹤0.01% 1511
2015
Q2
$11.1M Buy
275,042
+27,157
+11% +$1.1M 0.01% 1338
2015
Q1
$12.2M Buy
247,885
+1,808
+0.7% +$88.9K 0.01% 1233
2014
Q4
$11.2M Buy
+246,077
New +$11.2M 0.01% 1242